蔡嘉哲蕭世鴻Shih-Hong Siao微生物免疫研究所2026-10-299999-12-312013https://handle.ncl.edu.tw/11296/cejmh8https://scholars.csmu.edu.tw/handle/123456789/35948目的:類風溼性關節炎(RA)與牙周病(PD)關係密切,兩者的病徵很類似都是慢性發炎造成關節或是齒槽骨的損傷。有研究指出類風濕性關節炎的病患罹患牙周病的比率比起其他人約高出兩倍。造成牙周病的主要致病菌牙齦卟啉單孢菌(Porphyromonas gingivalis)有許多毒理因子不但可以引起發炎反應,甚至可以幫助細菌躲避免疫系統的攻擊,其中一重要的毒理因子: Arg-gingipain A (RgpA)已經被證實可以分解宿主的免疫球蛋白、補體、以及細胞激素等,並且會造成血管通透性增加進而加劇發炎反應。本研究想藉由偵測類風濕性關節炎以及其他自體免疫病患血清中是否有抗RgpA抗體以及觀察病情嚴重程度是否與抗體效價有關連。材料與方法:利用molecular cloning 技術將Porphyromonas gingivalis 之RgpA蛋白分成酵素活性區(catalytic domain)以及血球凝集區(hemagglutinindomain)分別大量表達後純化,再以酵素免疫分析法(ELISA)分析90位類風溼性關節炎(rheumatoid arthritis, RA)、38 位全身性紅斑性狼瘡(systemic lupus erythematosus, SLE)、15 位非RA、SLE 之自體免疫病患以及11 位對照組(normal control)血清內是否含有抗hemagglutinin domain 或抗catalytic domain 之抗體。結果:實驗結果發現共有40 位病人有抗RgpA hemagglutinin domain 的抗體,0 位病人有抗RgpA catalytic domain 抗體。其中90 位RA 病人中有29 人帶有抗RgpA hemagglutinin domain 抗體(32.2%),38 位SLE病人中有6 人帶有抗RgpA hemagglutinin domain 抗體(15.8%),15 位非RA、SLE 之自體免疫病人中有5 人帶有抗RgpA hemagglutinindomain 抗體(33.3%)。在RA 病人群中,抗RgpA hemagglutinin domain抗體陽性比率明顯高於對照組(p<0.05),而所有族群之抗RgpAcatalytic domain 抗體與對照組相比則無統計學上的意義(p>0.05)。結論:我們首次偵測及分析自體免疫病人中抗RgpA 蛋白之抗體情形。結果顯示RgpA catalytic domain 可能較不具抗原性,所以在所有人的血清中都無法偵測到特異性抗體存在。而在RgpA hemagglutinindomain 方面,RA 病人中帶有RgpA hemagglutinin domain 抗體的陽性比率明顯高於對照組及其他族群,這也和先前其他團隊研究RA 病人較容易罹患牙周病結果一致,未來需進一步釐清RgpA 如何參與RA之致病機轉。ObjectiveIncreasing evidences have suggested a high correlation betweenrheumatoid arthritis (RA) and periodontitis (PD). Both inflammatorydiseases share a common aetiololgy and pathology characterized by jointdestruction or alveolar bone resorption. Previous studies have shown thatpatients with RA have a two times increased incidence of expressing mildto severe PD, compared with healthy people. The main pathogen ofperiodontitis, Porphyromonas gingivalis, possesses numerous virulencefactors which can elicit severe immune response. Arg-gingipain A (RgpA),one of the virulence factors , has been reported to degrade a variety ofhost proteins, including immunoglobulins, complement proteins,cytokines, and increases vascular permeability to enhance leukocyterecruitment to the infected region, and finally caused inflammation. Inthis study, we detect anti-RgpA antibody in patients with autoimmunedisease by using recombinant RgpA protein and further analyze whetherthere is a correlation between anti-RgpA antibody and RA.Methods:RgpA hemagglutinin domain and RgpA catalytic domain werecloned respectively. ELISAs using RgpA hemagglutinin and RgpAcatalytic domain were developed and antibody reactivities examined inpatients with RA (n=90), SLE (n=38), healthy normal control (n=11), andindividuals with neither RA nor SLE patients (n=15).Results:In analysis of anti-RgpA catalytic domain antibodies, no one wasfound to react with RgpA catalytic domain. In analysis of anti-RgpAhemagglutinin domain antibodies, 29 of 90 RA patients (32.2%), 6 of 38SLE patients (15.8%), 5 of 15 neither RA nor SLE patients (33.3%) werefound to react with RgpA hemagglutinin domain. The titer of anti-RgpAhemagglutinin domain antibodies in RA patients was significantly higherthan that of the healthy normal control group (p<0.05). Antibodies toRgpA catalytic domain in each of disease groups were found nosignificant difference compared to that of healthy normal control group (p>0.05).Conclusion:Our results showed that RgpA catalytic domain does not possessantigenic property whereas RgpA hemagglutinin domain exhibit excellentantigenic property which can elicit immune response to produce specificantibodies against themselves. Patients with RA have higher titer ofanti-RgpA hemagglutinin domain antiboies among the disease groups.Our results were also consistent with other people’s study that patientswith RA had a two times increased prevalence of expressing mild tosevere PD. The relationships between anti- RgpA hemagglutinin domainantiboies and rheumatoid arthritis need to be further elucidated.類風濕性關節炎與抗牙齦痛蛋白A之抗體thesis